April 24, 2024Regulatory actions for April 24, 2024Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abeona, Astrazeneca, Averoa, Beigene, Edgewise, Immunitybio, Innocan, Medivir, Oncoc4, Revive, Tiziana.
April 24, 2024Other news to note for April 24, 2024Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aubex, Bighat, Biolojic, Endo, Exopharm, Glysious, J&J, Hami, Merck & Co., Moderna, Openai, Nektar, Tetra, Tryp, Tryptamine, Vivoryon.